Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial – - podcast episode cover

Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial –

Feb 22, 2023
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

https://psychiatry.dev/wp-content/uploads/speaker/post-11939.mp3?cb=1677095420.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial – Monire Karbalaee et

Full EntryEfficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial –

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial – | Psychiatry.dev - All Abstracts TTS podcast - Listen or read transcript on Metacast